Prominent Players - Ventricular Assist Devices Industry

The market for Ventricular Assist Devices is expanding as a result of the prevalence of heart failure patients around the world, technological advancements in the field of ventricular assist devices, and increased public knowledge of heart failure and available treatment options. Additionally, a sizeable patient population suffering from cardiovascular disease and growth and innovation in the healthcare industry are both contributing to the growth of the market for ventricular assist devices. The increasing prevalence of cardiovascular diseases like heart failure and other conditions that can induce heart failure has elevated the need for VADs even more.   Due to the rise in demand for better healthcare services, major government investments to upgrade the healthcare infrastructure, and the growth of the medical tourism sector in emerging nations, the healthcare sector in emerging economies is expanding at a rapid rate.

Top Companies in the Ventricular Assist Devices Industry:

1. Abbott Laboratories:

Abbott Laboratories is a medical device and health care company based in America. It was founded in the year 1888 by Wallace Calvin Abbott. The headquarters are located in Abbott Park, Illinois, U.S. The company sells medical devices, branded generic medicines and nutritional products. Abbott’s products include MitraClip, FreeStyle Libre, Pedialyte, and Ensure. In January 2022, the company introduced Lingo, which is a line of consumer bio wearable sensors known to collect a range of biological reading to optimize exercise and nutrition regimens.

2. Evaheart, Inc.:

Evaheart, Inc.: Creator of an implantable left ventricular assist device intended to lessen severe heart failure. The company's cardiac assistance devices are implantable mechanical pumps with an open-vane design and a hydraulically suspended impeller system that offer flat PQ curve pump performance, allowing patients with heart disease to receive support blood flow in the event of catastrophic heart failure. Established in 2003. Admin centre in the U.S.

3. AdjuCor GmbH:

AdjuCor GmbH: The creator of a heart-assist device for those with severe heart issues. The company creates a device that helps the heart while completely avoiding the risky aspect of blood contact, utilising technology to cover the sick heart and support it in its function. This enables medical professionals to better care for patients with heart failure and enhance their quality of life. 2012. German city of Munich for headquarters.

4. LivaNova PLC:

LivaNova PLC: U.K.-based Cyberonics in the US and Sorin in Italy came together to create LivaNova. The medical device company focuses primarily on cardiovascular and cardiopulmonary treatments (including surgical heart valves, heart-lung machines, and oxygenation equipment), as well as neuromodulation devices for depression and treatment-resistant epilepsy.  Started in 1987. Located in England, in the United Kingdom. Today, market-leading medical technology business LivaNova PLC announced the completion of its acquisition.

5. Carmat SA:

Carmat SA: The company Carmat is situated in France and works on developing and manufacturing heart prosthetics. It works on the creation of biocompatible and implantable orthotopic artificial hearts for the treatment of heart failure patients. The business also creates the product's control, remote diagnosis, and power supply systems. Headquarters in France, at Velizy Villacoublay. With subscription agreements totaling 22 million euros, CARMAT begins a capital increase for about 30 million euros.

6. Fineheart:

Fineheart: Manufacturer of implantable cardiac devices for the treatment of cardiovascular conditions. The company's product is a novel, wirelessly powered, fully implantable mechanical circulatory support device that can maximise cardiac output while maintaining the heart's natural contractility, allowing patients to recover their normal cardiac output and enabling people with heart failure to resume normal quality of life. Created in 2010. Headquarters in France's Pessac. Awarded a grant of €2.5 million by the prestigious EIC Accelerator Programme, FineHeart will use the money to develop and conduct clinical trials for its ICOMS FLOWMAKER® device.

7. Windmill Cardiovascular Systems:

Windmill Cardiovascular Systems: maker of medical equipment for treating heart failure. For the treatment of heart failure, the business develops left ventricular assist devices. Created in Founded 2005. United States headquarters.

Definition:

A ventricular assist device, or VAD, is a mechanical pump used to support heart function and blood flow in people with weak or failing hearts.